Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Become a Member
Explore Different Ways to Give
Create a Legacy
Join IASLC's Partners for Thoracic Cancer Care
Recognizing Our Donors
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Education
Conferences & Education
Conferences
Webinars
Online Learning: Lung Cancer 360
Lung Cancer Considered Podcast
WCLC 2024
Science & Research
Science & Research
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Research Grant Program
Research Grant Program
Research Grant Recipients
IASLC Academy
Publications, Resources & Guidelines
Membership
Membership
Become a Member
Renew Your Membership
Early-Career Opportunities
Partners Society Membership Offers
Patients & Caregivers
Patients & Caregivers
STARS Training
Lung Cancer Awareness Month
News
News
IASLC Lung Cancer News
WCLC 2024 News
Press Releases
Search
Fulltext search
Fulltext search
Search
Displaying 253 - 264 items out of 286 results
Press release
Journal of Thoracic Oncology 2023 Impact Factor Increases Over Rating in 2022; JTO Clinical and Research Reports Off to a Strong Start
Press release
Insufficient Evidence to Recommend Low-Dose CT Screening in Never Smokers Lung Cancer Screening: New Insights and Ongoing Debates
Press release
A Bright Future for Lung Cancer Care
Press release
Oncology Conference Registration Fraud: Be on Alert, Experts Warn
Press release
International Lung Cancer Experts Seek Public Comments on Updated Molecular Testing Guideline to Improve Patient Selection and Targeted Therapies
Press release
Datopotamab Deruxtecan Does Not Meet Its Secondary Primary Endpoint in TROPION-Lung01, But Researchers Believe Therapy is Still Beneficial for Some Patients with Non-Squamous NSCLC
Press release
Osimertinib With Savolitinib Demonstrates Stronger Efficacy Than Osimertinib Alone in Patients Who Do Not Respond Well to EGFR-TKIs Therapy
Press release
Zongertinib Demonstrates Promising Efficacy in Patients with HER2-Mutant NSCLC: Primary Phase Ib Analysis of Beamion LUNG-1
Press release
Breakthrough Therapy BAY 2927088 Demonstrates ‘Rapid, Substantial and Durable Responses’ in Patients with HER2-Mutant NSCLC
Press release
Results from the FURTHER Trial Demonstrate Firmonertinib is a Promising Potential Therapy for Patients with NSCLC with EGFR PACC Mutations
Press release
Artificial Intelligence Method Transforms Gene Mutation Prediction in Lung Cancer: DeepGEM Data Releases at IASLC 2024 World Conference on Lung Cancer
Press release
Research Shows Pathway to Developing Predictive Biomarkers for Immune Checkpoint Inhibitors
Pagination
First
First page
‹
Previous page
…
16
17
18
19
20
21
22
23
24
›
Next page
Last
Last page